Research/Development

Viking Therapeutics’ inventory greater than doubles as traders cheer low cost entry to weight-loss-drug craze

This stock-fund supervisor outperforms with ‘fixer-uppers’

This fast-growing nation is taming inflation and in robust monetary form — and its inventory market is looking

Iovance inventory drops 24% after it halts cancer-drug trial

Five obesity-drug tendencies to observe in 2024: Who can compete with Eli Lilly and Novo Nordisk? 

Sanofi suffers main blow as its cutting-edge most cancers drug disappoints in Phase III trials

Roche strikes $3.1 billion deal to purchase obesity-drug maker Carmot Therapeutics in race to rival Novo Nordisk’s Ozempic

Novo Nordisk’s Wegovy cuts danger of coronary heart assault and stroke by 20% amongst folks with out diabetes, examine finds

Eli Lilly will get FDA approval for brand spanking new weight problems drug

Amgen’s inventory hit by expectations its weight problems pipeline is going through an extended wait